Author

Jeroen Michiel Jansen 1

1 Onze Lieve Vrouwe Gasthuis,Amsterdam,Netherlands

DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION

Maurice Russel, Pepijn Thomas, Maarten te Groen, Rachel West, Lisa S. Smits, Jeroen Michiel Jansen, Frank Hoentjen, Tessa E.H. Römkens

INFLUENCE OF ANTIBIOTIC DURATION IN CHOLANGITIS AFTER SUCCESSFUL DRAINAGE BY ERCP

Britt ten Böhmer, Sylke Haal, Sebastiaan Balkema, A.C.T.M. Depla, Paul Fockens, Jeanin E. van Hooft, Jeroen Michiel Jansen, S.D. Kuiken, B.I. Liberov, E van Soest, Rogier P. Voermans

LONG-TERM HEALTH OUTCOMES OF 1000 CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE IN THE ANTI-TNF ERA

Shannon Kanis, Sanne Modderman, Johanna Caroline Escher, Ruud Beukers, K.H.N. (Nanne) de Boer, Alexander Bodelier, ACTM Depla, Gerard Dijkstra, Anne-Baue Van Dijk, Lennard P.L. Gilissen, Frank Hoentjen, Jeroen Michiel Jansen, Johannes Kuijvenhoven, Nofel Mahmmod, R. Mallant, Andrea E. Van Der Meulen - De Jong, Anahita Noruz

REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Pepijn Thomas, Nathan den Broeder, Rachel West, Maurice Russel, Tessa E.H. Römkens, Frank Hoentjen, Jeroen Michiel Jansen

SIMILAR TRIAL - EFFICACY OF INFLIXIMAB-BIOSIMILAR COMPARED TO INFLIXIMAB-BIOLOGICAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN REMISSION - A RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE 4 NONINFERIORITY TRIAL

Adrian Geurt Volkers, Jeroen Michiel Jansen

TRANSANAL ENDOSCOPIC MICROSURGERY VERSUS ENDOSCOPIC MUCOSAL RESECTION FOR LARGE RECTAL ADENOMAS (TREND-STUDY).

Renée M. Barendse, Gijsbert D. Musters, Eelco J. R. de Graaf, Frank J.C. van den Broek, Esther C.J. Consten, Pascal G. Doornebosch, James C.H. Hardwick, Ignace C de Hingh, Christiaan Hoff, Jeroen Michiel Jansen, A.W. M. van Milligen de Wit, George van der Schelling, Erik Jan Schoon, Matthijs P. Schwartz, Bas L.A.M. Weusten,

Item 1 - 6 / 11
1
2